Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Nuvectis Pharma Inc | NVCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
6.43 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
5/08/2024 | 9:05 | IHNW | FeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement |
5/07/2024 | 16:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
5/07/2024 | 09:13 | EDGAR2 | Form 8-K - Current report |
3/05/2024 | 17:20 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
3/05/2024 | 08:17 | EDGAR2 | Form 8-K - Current report |
1/05/2024 | 16:31 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
1/05/2024 | 16:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/08/2023 | 08:39 | EDGAR2 | Form 8-K - Current report |
11/08/2023 | 07:45 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
9/12/2023 | 08:16 | EDGAR2 | Form 8-K - Current report |
8/17/2023 | 09:18 | EDGAR2 | Form 8-K - Current report |
8/09/2023 | 16:51 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
8/09/2023 | 16:29 | EDGAR2 | Form 8-K - Current report |
8/09/2023 | 16:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
7/03/2023 | 08:00 | EDGAR2 | Form 8-K - Current report |